List of Excipients in API tranylcypromine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing tranylcypromine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | ANHYDROUS CITRIC ACID | |
| Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | CARNAUBA WAX | |
| Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | CELLULOSE, MICROCRYSTALLINE | |
| Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | CROSCARMELLOSE SODIUM | |
| Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | D&C RED NO. 7 | |
| Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | FD&C BLUE NO. 2 | |
| Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | FD&C YELLOW NO. 6 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing tranylcypromine
Detailed excipient profiles for tranylcypromine
Excipient focus: ANHYDROUS CITRIC ACID
tranylcypromine drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: CALCIUM SULFATE
tranylcypromine drug variants containing CALCIUM SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | tranylcypromine sulfate | 47781-517 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing CALCIUM SULFATE
Excipient focus: CALCIUM SULFATE DIHYDRATE
tranylcypromine drug variants containing CALCIUM SULFATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
| Novitium Pharma LLC | tranylcypromine | 70954-538 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing CALCIUM SULFATE DIHYDRATE
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
tranylcypromine drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
| Novitium Pharma LLC | tranylcypromine | 70954-538 |
| Alvogen Inc | tranylcypromine sulfate | 47781-517 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CARMINIC ACID
tranylcypromine drug variants containing CARMINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | tranylcypromine | 0527-3010 |
| Solco Healthcare US LLC | tranylcypromine | 43547-655 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing CARMINIC ACID
Excipient focus: CARNAUBA WAX
tranylcypromine drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
tranylcypromine drug variants containing CELLULOSE, MICROCRYSTALLINE
tranylcypromine drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
tranylcypromine drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: CROSCARMELLOSE SODIUM
tranylcypromine drug variants containing CROSCARMELLOSE SODIUM
tranylcypromine drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | tranylcypromine | 0527-3010 |
| Solco Healthcare US LLC | tranylcypromine | 43547-655 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 7
tranylcypromine drug variants containing D&C RED NO. 7
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
| Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing D&C RED NO. 7
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
tranylcypromine drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | tranylcypromine sulfate | 49884-032 |
| Golden State Medical Supply Inc | tranylcypromine sulfate | 60429-210 |
| Bryant Ranch Prepack | tranylcypromine sulfate | 63629-2247 |
| Strides Pharma Science Limited | tranylcypromine sulfate | 64380-176 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: FD&C BLUE NO. 2
tranylcypromine drug variants containing FD&C BLUE NO. 2
tranylcypromine drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 40
tranylcypromine drug variants containing FD&C RED NO. 40
tranylcypromine drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
tranylcypromine drug variants containing FD&C YELLOW NO. 6
tranylcypromine drug variants not containing FD&C YELLOW NO. 6
Excipient focus: GELATIN
tranylcypromine drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
| Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing GELATIN
Excipient focus: HYPROMELLOSE
tranylcypromine drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | tranylcypromine sulfate | 47781-517 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
tranylcypromine drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
| Novitium Pharma LLC | tranylcypromine | 70954-538 |
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing HYPROMELLOSE 2910
Excipient focus: LACTOSE
tranylcypromine drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
| Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing LACTOSE
Excipient focus: MAGNESIUM PALMITOSTEARATE
tranylcypromine drug variants containing MAGNESIUM PALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | tranylcypromine | 0527-3010 |
| Solco Healthcare US LLC | tranylcypromine | 43547-655 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing MAGNESIUM PALMITOSTEARATE
Excipient focus: MAGNESIUM STEARATE
tranylcypromine drug variants containing MAGNESIUM STEARATE
tranylcypromine drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | tranylcypromine | 0527-3010 |
| Solco Healthcare US LLC | tranylcypromine | 43547-655 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
tranylcypromine drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | tranylcypromine sulfate | 47781-517 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
tranylcypromine drug variants containing POLYETHYLENE GLYCOL 3350
tranylcypromine drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
tranylcypromine drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 6000
tranylcypromine drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
| Novitium Pharma LLC | tranylcypromine | 70954-538 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
tranylcypromine drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Concordia Pharmaceuticals Inc | tranylcypromine sulfate | 59212-447 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYVINYL ALCOHOL
tranylcypromine drug variants containing POLYVINYL ALCOHOL
tranylcypromine drug variants not containing POLYVINYL ALCOHOL
Excipient focus: SILICON DIOXIDE
tranylcypromine drug variants containing SILICON DIOXIDE
tranylcypromine drug variants not containing SILICON DIOXIDE
Excipient focus: STARCH, CORN
tranylcypromine drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | tranylcypromine | 0527-3010 |
| Marlex Pharmaceuticals Inc | tranylcypromine | 10135-739 |
| Solco Healthcare US LLC | tranylcypromine | 43547-655 |
| Novitium Pharma LLC | tranylcypromine | 70954-538 |
| Alvogen Inc | tranylcypromine sulfate | 47781-517 |
| >Company | >Ingredient | >NDC |
tranylcypromine drug variants not containing STARCH, CORN
Excipient focus: TALC
tranylcypromine drug variants containing TALC
tranylcypromine drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
tranylcypromine drug variants containing TITANIUM DIOXIDE
tranylcypromine drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
